SYNTHIA
Live / Registered — Registered (as of 26 Nov 2024)
What this means for you
Registered since 26 Nov 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 87825579
- Registration number
- 7575011
- Mark type
- Stylized text
- Filed
- 08 Mar 2018
- Published for opposition
- 24 Sept 2024
- Registered
- 26 Nov 2024
- Attorney of record
- William C. Wright
Goods and services
- Class 009 — Scientific and electric apparatus: Electronic databases in the fields of drug development and drug manufacturing, recorded on computer media; bioinformatics software for storing, indexing, searching, retrieving, and accessing information about biological data for use in retrosynthesis, optimization of organic chemistry reactions and synthesis, assessing synthetic accessibility of real and virtual molecules, and drug discovery, drug development, and drug manufacturing; chemoinformatics software for storing, indexing, searching, retrieving, and accessing information about chemical compounds and chemical data for use in retrosynthesis, optimization of organic chemistry reactions and synthesis, assessing synthetic accessibility of real and virtual molecules, drug discovery, drug development, and drug manufacturing; software for use in biological and chemical modelling, analysis and information management for use in retrosynthesis, optimization of organic chemistry reactions and synthesis, assessing synthetic accessibility of real and virtual molecules, drug discovery, drug development, and drug manufacturing; software for computer-aided molecular design, data processing and data analysis for use in retrosynthesis, optimization of organic chemistry reactions and synthesis, assessing synthetic accessibility of real and virtual molecules, drug discovery, drug development, and drug manufacturing; chemical data analysis software for use in retrosynthesis, optimization of organic chemistry reactions and synthesis, assessing synthetic accessibility of real and virtual molecules, drug discovery, drug development, and drug manufacturing; drug discovery information systems software used to solve problems in connection with chemical syntheses for use in the field of organic chemistry; none of the foregoing for use in connection with synthetic patients, simulated patients, synthetic electronic patient healthcare records, synthetic patient data and associated healthcare records, nor in the field of medical science and medical consultancy
- Class 038 — Telecommunications services: Providing access to databases for use in retrosynthesis, optimization of organic chemistry reactions and synthesis, assessing synthetic accessibility of real and virtual molecules, drug discovery, drug development, and drug manufacturing; none of the foregoing for use in connection with synthetic patients, simulated patients, synthetic electronic patient healthcare records, synthetic patient data and associated healthcare records, nor in the field of medical science and medical consultancy
- Class 042 — Scientific and technological services: Biotechnology and pharmaceutical research relating to retrosynthesis, optimization of organic chemistry reactions and synthesis, assessing synthetic accessibility of real and virtual molecules, and drug development; professional consultancy in relation to drug development; scientific research and development for others; scientific research in the nature of analysis and preparation of data relating to retrosynthesis, optimization of organic chemistry reactions and synthesis, assessing synthetic accessibility of real and virtual molecules, drug discovery and drug development; provision of information in relation to drug discovery and drug development; provision of scientific information related to pharmacy; none of the foregoing for use in connection with synthetic patients, simulated patients, synthetic electronic patient healthcare records, synthetic patient data and associated healthcare records, nor in the field of medical science and medical consultancy
- Class 045 — Legal and security services: Licensing of computer software used for retrosynthesis, optimization of organic chemistry reactions and synthesis, assessing synthetic accessibility of real and virtual molecules, drug discovery, drug development, and drug manufacturing; none of the foregoing for use in connection with synthetic patients, simulated patients, synthetic electronic patient healthcare records, synthetic patient data and associated healthcare records, nor in the field of medical science and medical consultancy
Owner
- Merck KGaA, Darmstadt, DE
- Merck KGaA, Darmstadt, DE
- Merck KGaA, Darmstadt, DE
Prosecution history
- 26 Nov 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 26 Nov 2024 — REGISTERED-PRINCIPAL REGISTER
- 24 Sept 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 24 Sept 2024 — PUBLISHED FOR OPPOSITION
- 04 Sept 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 15 Aug 2024 — ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
- 13 Aug 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 13 Jul 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 13 Jul 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 13 Jul 2024 — TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
- 15 Apr 2024 — NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
- 15 Apr 2024 — INQUIRY TO SUSPENSION E-MAILED
- 15 Apr 2024 — SUSPENSION INQUIRY WRITTEN
- 12 Apr 2024 — SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
- 11 Oct 2023 — REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED